Key result
In patients with sinus bradycardia and AT, mean time to first AT recurrence (48.2 days) was significantly longer than time between first and second episode (10.3 days, P<0.01).
Observational (n=240)
Yes
Atrial tachyarrhythmia recurrences in bradycardia patients do not follow a uniform or random distribution, questioning the validity of using time to first recurrence as a clinical outcome in AT therapy trials.
Questions time-to-first-recurrence as AT trial endpoint in bradycardia; hypothesis-generating for non-uniform recurrence patterns.
INTRODUCTION: New-generation pacemakers allow continuous atrial tachyarrhythmia (AT) monitoring that provides accurate information about AT type, frequency, burden, and temporary evolution. METHODS AND RESULTS: We performed a prospective multicenter study to describe AT temporal patterns in patients with sinus bradycardia and AT. Two hundred forty patients (123 men; age 71 +/- 8 years) were implanted with a DDDRP pacemaker (model AT500, Medtronic Inc.). All patients were followed for 13 months. The first-month stabilization period of all patients was discarded from analysis. Seventy percent of patients had AT recurrences. Mean time to first AT recurrence (48.2 days, 95% confidence interval [CI] 37.0-59.5 days) was significantly longer than the time between first and second AT episode (10.3 days, 95% CI 6.7-13.9 days, P < 0.01). A minority of patients had a uniform time distribution of AT recurrences: <25% of patients had AT episodes in more than 6 of the 12 months considered in the study. The probability density function of consecutive sinus rhythm days between AT episodes was calculated for each of 40 patients who experienced >25 AT episodes and fitted by power law and exponential functions. The best fit was obtained by power law function in 60% of patients, by exponential function in 10%, and the two models gave comparable results in 30% of patients. CONCLUSION: In our population of patients with a history of sinus bradycardia and AT who were implanted with a new device equipped with atrial pacing therapies, 30% did not experience AT recurrences in the 12-month study period. Analysis of interevent time showed that in 60% of patients AT recurrences do not follow a uniform or random distribution. These findings bring into question the use of cross-over design and time to first AT recurrence as a clinical outcome in trials for AT therapy in this patient population.
No takes yet. Share an insight, caveat, or question.
Ricci et al. (2004) conducted an observational in Sinus bradycardia and atrial tachyarrhythmia (n=240). DDDRP pacemaker (model AT500) was evaluated on Mean time to first AT recurrence vs time between first and second AT episode (p=<0.01). In patients with sinus bradycardia and AT, mean time to first AT recurrence (48.2 days) was significantly longer than time between first and second episode (10.3 days, P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: